Search clinical trials for: BMS-986177
Total 3157 results
-
Bristol-Myers SquibbTerminatedLupus NephritisUnited States, Taiwan, Spain, United Kingdom, Netherlands, Germany, China, Australia, Belgium, Mexico, Korea, Republic of, Czechia, Russian Federation, Israel, Canada, Italy
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedGastric Cancer | Esophageal Cancer | Gastric Adenocarcinoma | Esophagogastric Cancer | Gastroesophageal Junction Adenocarcinoma | Esophagus Cancer | Gastroesophageal Junction Squamous Cell CarcinomaUnited States
-
Bluedrop Medical LimitedRecruitingDiabetic FootUnited States
-
Bristol-Myers SquibbRecruitingSystemic Lupus ErythematosusUnited States, Taiwan, Japan, Brazil, Colombia, Germany, Poland, Puerto Rico, China, Mexico, Argentina, France, Chile, Australia, India, Spain, United Kingdom, Romania, Ireland
-
R-PharmCompletedStomach NeoplasmsKorea, Republic of, Taiwan, Japan, Singapore, Hong Kong
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbTerminatedAlzheimer's DiseaseSweden, United States, Canada, Denmark, France, Finland
-
Bristol-Myers SquibbTerminatedNon Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbWithdrawnHepatitis C VirusUnited States
-
CelgeneNot yet recruitingRenal ImpairmentUnited States
-
Allyx TherapeuticsYale University; National Institute on Aging (NIA)RecruitingAlzheimer's DiseaseUnited States
-
Bristol-Myers SquibbCelgeneCompleted
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
Aegerion Pharmaceuticals, Inc.FDA Office of Orphan Products DevelopmentCompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
InspireMDWithdrawnST Segment Elevated Myocardial InfarctionUnited Kingdom
-
Aegerion Pharmaceuticals, Inc.University of Pennsylvania; Doris Duke Charitable FoundationCompletedHomozygous Familial HypercholesterolemiaUnited States
-
CelgeneWithdrawnMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbCompletedAlzheimer's Disease
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHealthy | Hepatitis CUnited States, Puerto Rico
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbCompletedHealthy Subjects and Atopic Dermatitis SubjectsUnited Kingdom
-
The Lymphoma Academic Research OrganisationLymphoma Study AssociationNot yet recruitingRefractory High Grade B-Cell Lymphoma | Diffuse Large B-cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaFrance
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Bristol-Myers SquibbCompletedHepatic ImpairmentUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited Kingdom, Netherlands
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerItaly, Australia, United States, Spain, Romania, Argentina, Canada, Chile, Finland, Germany, Poland
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompletedMelanoma | Skin CancerUnited States, Canada, Netherlands, Spain, Australia, Italy, Japan, Germany, Ireland, United Kingdom, Czechia, Switzerland, Poland, France, Greece, New Zealand
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Bristol-Myers SquibbClovis Oncology, Inc.CompletedAdvanced Gastric CancerUnited States, Israel, Netherlands, Canada, Italy, Australia, Germany, Singapore, Switzerland
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
R-PharmCompletedMetastatic Pancreatic CancerUnited States
-
Bristol-Myers SquibbRecruitingAlzheimer Disease, Early OnsetUnited States, Australia, Belgium, Canada, France, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, United Kingdom, Denmark, Germany, Italy, Poland
-
CelgeneRecruitingEosinophilic EsophagitisUnited States
-
The University of Hong KongNot yet recruiting
-
Bristol-Myers SquibbCompletedModerate Liver Impairment | Severe Liver ImpairmentUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedCongestive Heart Failure | Liver Dysfunction | Heart Decompensation | Cardiac Failure | Liver Insufficiency | Myocardial Failure | Hepatic FailureHungary, Poland
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbCompletedChronic Hepatitis CFrance, United States, Puerto Rico
-
Bristol-Myers SquibbCompletedRheumatoid ArthritisUnited States
-
CelgeneActive, not recruitingEosinophilic GastroenteritisJapan
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States